Cancer Immunotherapy – Is It Really a “Game-Changer”?
Traditionally, cancer is treated by surgery, chemotherapy or radiotherapy. However, some of the most exciting breakthroughs are now being made using another type of treatment called immunotherapy. This treatment is well established in other medical conditions such as rheumatoid arthritis and allergic asthma. Numerous sources now declare immunotherapy to be a “game-changer” in cancer treatment and we will discuss that here.
Advances in Cancer Research and Insurance
The International Agency for Research on Cancer (IARC) was created more than 50 years ago to foster global collaboration on cancer control. Today more effective therapies mean mortality rates no longer reflect incidence rates; there are now more cancer survivors partly due to advances that enable early diagnosis.
Cancer Immunotherapy: A Rapidly Expanding Frontier
This article reviews the recent and unprecedented acceleration in the understanding of cancer pathophysiology which has led to the subsequent development of novel cancer immunotherapies. In part, this new direction in cancer treatment has been advanced by a greater understanding of individual patient genomics and has contributed to the realization of the so-called “precision medicine” era.
Proton Beam Radiation Therapy (SCOR inFORM)
This article focuses on Proton Beam Radiation Therapy: its history, how it works, its use in the treatment of different cancers, and implications for insurers.
Fewer Deaths from Leading Causes
The number of fatalities caused by heart disease, cancer, stroke, unintentional injuries and diabetes - the five leading causes of death in the US - has fallen, according to a report published in JAMA.
QuickStats: Age-Adjusted Death Rates from Cancer, by U.S. Census Region and Year — United States, 1970–2013
The age-adjusted cancer death rates increased significantly from 1970 to 1990 in each census region in the United States. The rate increased an average of 0.16% per year in the Northeast, 0.38% in the Midwest, 0.71% in the South, and 0.27% in the West. Since 1990, the rates have decreased at an ever faster rate, down on average by 1.41% in the Northeast, 1.02% in the Midwest, 1.15% in the South, and 1.30% in the West each year.
Invasive Cancer Incidence and Survival — United States, 2011
Because of improvements in early detection and treatment of cancer, the proportion of persons with cancer who survive ≥5 years after diagnosis has increased.